TY - JOUR
T1 - When the Mind Comes to Live Inside the Body
T2 - The Ontogeny of the Perceptual Control Clock
AU - Ferber, Sari Goldstein
AU - Geva, Ronny
AU - Weller, Aron
N1 - Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023/1
Y1 - 2023/1
N2 - In this editorial, we discuss the neurobiological processes underlying the early emergence of awareness that we term the “when” and “how” the mind comes to live inside the body. We describe an accumulative developmental process starting during embryonic life and continuing to fetal and postnatal development, of coupling of heart rate, body movements, and sleep states on the behavioral level with underlying mechanisms on the structural, functional, cellular, and molecular lev-els. A developmental perspective is proposed based on Perceptual Control Theory (PCT). This in-cludes a developing sequence of modules starting from early sensing of neural intensities to early manifestation of human mindful capacities. We also address pharmacological treatments adminis-tered to preterm infants, which may interfere with this development, and highlight the need to consider this potential “side effect” of current pharmaceuticals when developing novel phar-macogenomic treatments.
AB - In this editorial, we discuss the neurobiological processes underlying the early emergence of awareness that we term the “when” and “how” the mind comes to live inside the body. We describe an accumulative developmental process starting during embryonic life and continuing to fetal and postnatal development, of coupling of heart rate, body movements, and sleep states on the behavioral level with underlying mechanisms on the structural, functional, cellular, and molecular lev-els. A developmental perspective is proposed based on Perceptual Control Theory (PCT). This in-cludes a developing sequence of modules starting from early sensing of neural intensities to early manifestation of human mindful capacities. We also address pharmacological treatments adminis-tered to preterm infants, which may interfere with this development, and highlight the need to consider this potential “side effect” of current pharmaceuticals when developing novel phar-macogenomic treatments.
KW - Fetal development
KW - brainstem
KW - coupling
KW - epigenomics
KW - preterm infants
KW - thalamus
UR - http://www.scopus.com/inward/record.url?scp=85144441870&partnerID=8YFLogxK
U2 - 10.2174/1570159X20666220411095508
DO - 10.2174/1570159X20666220411095508
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???
C2 - 35410607
AN - SCOPUS:85144441870
SN - 1570-159X
VL - 21
SP - 13
EP - 21
JO - Current Neuropharmacology
JF - Current Neuropharmacology
IS - 1
ER -